|
|
Volumn 26, Issue 1, 2008, Pages 106-107
|
|
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Mahajan NP, Liu Y, Majumder S, Warren MR, Parker CE, Mohler JL, Earp HS, Whang YE, Lineberger Comprehensive Cancer Center, Departments of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACK1 ENZYME;
ANDROGEN;
ANDROGEN RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
NEU DIFFERENTIATION FACTOR;
PROTEIN CDC42;
PROTEIN TYROSINE KINASE;
TYROSINE;
UNCLASSIFIED DRUG;
CANCER CELL;
CANCER GROWTH;
CELL STRAIN LNCAP;
GENE EXPRESSION;
HUMAN;
MUTATION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN PHOSPHORYLATION;
SHORT SURVEY;
TUMOR XENOGRAFT;
|
|
EID: 37649025950
PISSN: 10781439
EISSN: None
Source Type: Journal
DOI: 10.1016/j.urolonc.2007.11.019 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|